Cyclooxygenase-1 and -2 isoenzymes

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, are key regulators of prostanoid biosynthesis.
• These isoenzymes, encoded by COX-1 and COX-2 genes, exhibit distinct expression patterns and physiological roles.
• COX-2 is notably overexpressed in conditions such as rheumatoid arthritis and various cancers, including colorectal and breast cancer.

Purpose of the Study:

• To investigate the role of COX isoenzymes in prostanoid biosynthesis.
• To explore the therapeutic potential of targeting COX-2 for inflammatory and neoplastic diseases.

Main Methods:

• Analysis of COX-1 and COX-2 gene expression regulation by extracellular stimuli.
• Examination of prostanoid signaling pathways involving G-protein-coupled and nuclear receptors.
• Development and evaluation of COX-2-selective inhibitors.

Main Results:

• COX-1 and COX-2 isoenzymes catalyze critical steps in prostanoid synthesis.
• Extracellular factors modulate COX-1 and COX-2 gene expression transcriptionally and post-transcriptionally.
• COX-2 overexpression is linked to rheumatoid arthritis and specific cancers.
• Prostanoids mediate signaling through various receptor types.
• COX-2-selective inhibitors are under development for therapeutic applications.

Conclusions:

• Targeting COX isoenzyme activity and/or expression presents a promising strategy for developing next-generation anti-inflammatory and anti-neoplastic therapeutics.
• COX-2 selective inhibition holds potential for managing inflammatory conditions and combating cancer growth.